文献速递腹部CTMRPET

直肠癌局部复发:从检出到结构化报告

Local recurrence in rectal cancer: from detection to structured reporting.
PubMed 文献 · Abdom Radiol (NY) · 2026-08-07

本文综述直肠癌局部复发的影像评估策略。复发多见于术后3年内及手术床附近,CT常首先提示可疑病灶,但鉴别肿瘤与纤维化能力有限。推荐高危或可疑病例行高分辨率盆腔MRI,并结合DWI、增强序列评估可切除性,FDG-PET/CT用于疑难或排除转移。

要点

  • CT可疑或盆腔表现不明确时,应及时建议高分辨率盆腔MRI复发协议检查
  • MRI重点观察手术床邻近结构受累,以直接支持R0可切除性判断
  • FDG-PET/CT适用于CT/MRI难以定论或需排除远处转移的情况

核心结论

  • MRI是直肠癌盆腔局部复发定性、局部分期及可切除性评估的首选影像手段
  • FDG-PET/CT用于CT或MRI结果不明确及排除隐匿转移,但黏液腺癌、慢性炎症和小病灶可降低敏感性

研究设计与样本

  • 本文为综述,总结复发模式、多模态成像技术、陷阱、结构化报告及功能影像、影像组学和人工智能的新兴应用

关键影像表现/征象

  • 复发多位于手术床附近,纤维化和解剖变形可延误识别
  • CT发现盆腔可疑或不确定病灶时应进一步行高分辨率盆腔MRI
  • MRI的T2加权、扩散加权和增强序列有助于区分复发肿瘤与纤维化
  • 后盆腔复发时,骶骨MRI可显示骨髓浸润、皮质受累、骶孔侵犯及神经根延伸

诊断标准与关键数值

  • CT对鉴别盆腔活性肿瘤与术后或放疗后纤维化能力有限
  • MRI包括T2加权、DWI和增强序列,用于局部定性和分期
  • 完整R0切除为持久控制和生存提供最佳机会

临床应用与阅片要点

  • 对可疑CT表现应主动建议盆腔MRI复发协议而非仅报告CT所见
  • 后盆腔复发应加扫骶骨MRI以评估切缘和神经根受累
  • FDG-PET/MRI小样本研究显示有前景,但对神经周围播散和术式改变的价值尚不明确
  • 影像报告宜采用结构化方式,涵盖可切除性相关结构受累情况

局限性

  • FDG-PET/CT对黏液腺癌、慢性炎症和小体积病灶敏感性下降
  • FDG-PET/MRI改善判读的价值及对神经周围播散评估的增量价值尚未确立

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Despite advances in total mesorectal excision and neoadjuvant therapy, locally recurrent rectal cancer remains a clinically important source of pelvic morbidity and cancer-related mortality, affecting approximately 2-10% of the treated patients. Most recurrences develop within three years of surgery and often arise near the surgical bed, where fibrosis and distorted anatomy can delay detection. Early recognition is critical because complete R0 resection offers the best chance of durable disease control and survival. Imaging provides the anatomic and functional information required to diagnose pelvic recurrence and guide multidisciplinary management. Contrast-enhanced CT of the chest, abdomen, and pelvis is typically used for routine surveillance and often provides the first radiologic suspicion of recurrence, particularly by detecting distant metastases or pelvic disease. However, CT has a limited ability to distinguish viable tumor from postoperative or post-radiation fibrosis in the pelvis. Suspicious or equivocal CT findings should therefore prompt high-resolution pelvic MRI using a recurrence protocol. MRI, including T2-weighted, diffusion-weighted, and contrast-enhanced sequences, is the preferred modality for local characterization and staging. MRI helps differentiate recurrent tumor from fibrosis, defines locoregional extent, and evaluates involvement of adjacent structures that directly influence resectability. For posterior compartment recurrence, dedicated musculoskeletal MRI of the sacrum may further delineate marrow infiltration, cortical involvement, sacral foraminal invasion, and nerve root extension, supporting surgical planning and margin assessment. FDG-PET/CT is useful when CT or MRI findings are equivocal and for excluding unsuspected metastatic disease, although mucinous tumors, chronic inflammation, and small-volume disease may reduce sensitivity. Hybrid FDG-PET/MRI has shown promising performance in detecting pelvic recurrence in small studies and may reduce equivocal interpretations; however, its incremental value in evaluating perineural spread and altering surgical management has not been established. This review summarizes recurrence patterns, optimal multimodality imaging techniques, pitfalls, structured reporting, and emerging applications of functional imaging, radiomics, and artificial intelligence in the individualized management of these patients.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Hamza, Bizinoto, Vidal Leão, et al. Local recurrence in rectal cancer: from detection to structured reporting. Abdom Radiol (NY). 2026. PMID: 42566012. doi:10.1007/s00261-026-05722-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。